LnRiLWZpZWxke21hcmdpbi1ib3R0b206MC43NmVtfS50Yi1maWVsZC0tbGVmdHt0ZXh0LWFsaWduOmxlZnR9LnRiLWZpZWxkLS1jZW50ZXJ7dGV4dC1hbGlnbjpjZW50ZXJ9LnRiLWZpZWxkLS1yaWdodHt0ZXh0LWFsaWduOnJpZ2h0fS50Yi1maWVsZF9fc2t5cGVfcHJldmlld3twYWRkaW5nOjEwcHggMjBweDtib3JkZXItcmFkaXVzOjNweDtjb2xvcjojZmZmO2JhY2tncm91bmQ6IzAwYWZlZTtkaXNwbGF5OmlubGluZS1ibG9ja311bC5nbGlkZV9fc2xpZGVze21hcmdpbjowfQ==
TW9udHNlcnJhdDo2MDAscmVndWxhciw1MDA=
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
Tony Hu
Tulane University, USA
2024
TW9udHNlcnJhdDo2MDAscmVndWxhciw1MDA=
Dr. Tony Hu is a Professor at Tulane University holding expertise across Biochemistry and Molecular Biology, Biomedical Engineering, and Microbiology. As the esteemed Weatherhead Presidential Chair in Biotechnology Innovation, Dr. Hu is the founding director of Tulane’s Center for Intelligent Molecular Diagnostics. He is also a member of the National Academy of Inventors (NAI) and the American Institute of Medical and Biological Engineering (AIMBE). At the forefront of multi-omics engineering, nanomedicine, and mechanistic biomarker research, Dr. Hu’s approach is distinguished by leveraging nanotechnology to enhance assay accuracy and consistency. His inventions aim to redefine diagnostic paradigms for infectious and cancerous diseases, aiming for comprehensive diagnostic, prognostic, and therapeutic evaluation tools. Dr. Hu’s work has culminated in over 150 influential publications and 25 patent applications in the realm of nanomedicine, with 14 patents securing licenses from global entities. A mentor to 82 scholars from 21 nations, Dr. Hu has a legacy of nurturing talent that propels into prominent academic roles. His entrepreneurial acumen is evident as a co-founder of Intelligenome Inc. in Houston, TX, and NanoPin Technologies in New Orleans, LA, contributing to biotechnological innovation.
